Skip to main content
. 2016 Feb 5;9:671–679. doi: 10.2147/OTT.S100105

Figure 3.

Figure 3

Time to BM in the erlotinib group versus the chemotherapy group in subgroups of first-line treatment (A), second-line treatment (B), stage IIIB (C), stage IV (D), exon 19 deletion (E), and exon 21 L858R mutation (F).

Abbreviation: BM, brain metastasis.